Recombinant multi-species SLC39A12 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLC39A12 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Zinc is an essential cofactor for hundreds of enzymes. It is involved in protein, nucleic acid, carbohydrate, and lipid metabolism, as well as in the control of gene transcription, growth, development, and differentiation. SLC39A12 belongs to a subfamily of proteins that show structural characteristics of zinc transporters (Taylor and Nicholson, 2003 [PubMed 12659941]).[supplied by OMIM, Aug 2008]
The Alternative Names of target: Gm731,LIV-1 subfamily of ZIP zinc transporter 8 (LZT-Hs8),LZT-Hs8,SLC39A12,Slc39a12,Solute carrier family 39 member 12,ZIP-12,ZIP12,Zinc transporter ZIP12,Zrt- and Irt-like protein 12 (ZIP-12),bA570F3.1
Go
to SLC39A12 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP1735-Ag-1/ GM-Tg-hg-IP1735-Ag-2 | Human SLC39A12 protein | Human |
| GM-Tg-rg-IP1735-Ag-1/ GM-Tg-rg-IP1735-Ag-2 | Rat SLC39A12 protein | Rat |
| GM-Tg-mg-IP1735-Ag-1/ GM-Tg-mg-IP1735-Ag-2 | Mouse SLC39A12 protein | Mouse |
| GM-Tg-cynog-IP1735-Ag-1/ GM-Tg-cynog-IP1735-Ag-2 | Cynomolgus/Rhesus macaque SLC39A12 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP1735-Ag-1/ GM-Tg-felg-IP1735-Ag-2 | Feline SLC39A12 protein | Feline |
| GM-Tg-cang-IP1735-Ag-1/ GM-Tg-cang-IP1735-Ag-2 | Canine SLC39A12 protein | Canine |
| GM-Tg-bovg-IP1735-Ag-1/ GM-Tg-bovg-IP1735-Ag-2 | Bovine SLC39A12 protein | Bovine |
| GM-Tg-equg-IP1735-Ag-1/ GM-Tg-equg-IP1735-Ag-2 | Equine SLC39A12 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP1735-Ag-1/ GM-Tg-hg-IP1735-Ag-2;
GM-Tg-rg-IP1735-Ag-1/ GM-Tg-rg-IP1735-Ag-2;
GM-Tg-mg-IP1735-Ag-1/ GM-Tg-mg-IP1735-Ag-2; GM-Tg-cynog-IP1735-Ag-1/ GM-Tg-cynog-IP1735-Ag-2; GM-Tg-felg-IP1735-Ag-1/ GM-Tg-felg-IP1735-Ag-2; GM-Tg-cang-IP1735-Ag-1/ GM-Tg-cang-IP1735-Ag-2; GM-Tg-bovg-IP1735-Ag-1/ GM-Tg-bovg-IP1735-Ag-2; GM-Tg-equg-IP1735-Ag-1/ GM-Tg-equg-IP1735-Ag-2 |
| Products Name | SLC39A12 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SLC39A12 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLC39A12 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.